Mounjaro Al igual que Ozempic, Mounjaro se desarroll originalmente para tratar la diabetes tipo 2, pero actualmente tambin est autorizado de forma oficial como tratamiento para la prdida de peso
Primary Research References The core peer-reviewed publications underlying current Retatrutide research: Jastreboff AM et al
Participants who took Tirzepatide, which is the active ingredient in the weight loss drug Zepbound, also a GLP-1 agonist, lost 15%-21% of their body weight over a 72-week period, according to a study published in The New England Journal of Medicine
The UK and EU product information contains warnings about thyroid C-cell tumours, which differs from the US where these medications carry a boxed warning and formal contraindications for certain thyroid conditions
Takeaway Weight loss affects both fat and muscle
Do not take it with mineral oil